Today in FirstWord: dapagliflozin, Lucentis, Neupogen, Neulasta, Johnson & Johnson, Valeant, pertuzumab

Today in FirstWord: dapagliflozin, Lucentis, Neupogen, Neulasta, Johnson &amp; Johnson, Valeant, pertuzumab

FirstWord Pharmaceutical News for Monday, July 18, 2011

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional.  For more information on this time-saving tool, please visit www.firstwordpharma.com.

Business

Medicine

Business News

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit www.firstwordpharma.com.

Share FirstWord Pharmaceutical News for Monday, July 18, 2011

Sign up to save your podcasts

FirstWord Pharmaceutical News for Monday, July 18, 2011

FirstWord Pharmaceutical News for Monday, July 18, 2011